GLOBAL MIND SCREEN online mental health assessment

  • Global Sites
Login / Register
Vote Global Mind Screen for Anthill Smart 100 awards
Thanks to our huge number of supporters we came 4th in the Readers' Choice segment of Anthill's SMART 100 Top Innovations Awards for 2014!!!!
THANKS FROM THE MIND SCREEN TEAM
  • Practitioners
  • Public & Patients
  • Workplace Wellness
B2B Clock Nav Icon

Early Intervention

Find out why doing the Mind Screen early is the key to getting your patients better sooner.

Learn More
How It Works

Multi-Disorder Assessment

Find out why the Mind Screen is superior to single-disorder assessment tools.

Learn More
B2B Magnifying Glass Nav Icon

What Is A Mind Screen?

Find out what the Mind Screen includes.

Learn More
B2B Cog Nav Icon

How It Works

Find out how to use the Mind Screen in your daily work flow.

Learn More
B2B Dollar Nav Icon

Practice Benefits

Find out how using the Mind Screen will benefit you and your practice.

Learn More
B2B Testimonials Nav Icon

Testimonials

Find out what real practitioners and patients think of the Mind Screen.

Learn More
b2c_slider_icon_clock.png

Early Intervention

Find out why doing the Mind Screen is the key to getting better sooner.

Learn More
b2c_slider_icon_graph.png

Multi-Disorder Assessment

Find out why you will never go back to using single-disorder assessment tools.

Learn More
b2c_slider_icon_find_us.png

What Is A Mind Screen?

Find out what you get when you do a Mind Screen.

Learn More
b2c_slider_icon_cog.png

How it Works

Find out what to expect when doing a Mind Screen.

Learn More
b2c_slider_icon_testimonials.png

Patient Testimonials

Find out what others say about the Mind Screen.

Learn More
b2c_slider_icon_sthetoscope.png

Conditions Assessed

Find out about the 30+ conditions assessed by the Mind Screen.

Learn More
b2w_slider_icon_clock.png

Early Intervention

Find out why doing the Mind Screen early is the key to getting better and back to work sooner.

Learn More
B2W Graph Nav Icon

Multi-Disorder Assessment

Find out why the Mind Screen is simply better than single-disorder assessment tools.

 

Learn More
b2w_slider_icon_dollar.png

Mind Screen At Work

Find out how the Mind Screen will increase productivity and reduce costs at your workplace.

Learn More
b2w_slider_icon_handshake.png

EAP+

Find out why the Mind Screen EAP+ Workplace Program beats traditional EAP programs hands down.

Learn More
b2w_slider_icon_testimonials.png

What Others Say

Find out what others say about the Mind Screen.

Learn More
B2W Steth Nav Icon

Conditions Assessed

Find out about the 30+ conditions assessed by the Mind Screen.

Learn More
+ Open Menu
- Close Menu
  • Mind Screen
    • Cost of Poor Mental Health at Work
    • Mind Screen at Work
    • Workplace Mental Wellness Program
      • Pre-employment Assessment
      • Employee Assistance Program - EAP+
      • Mental Wellness & Resilience Program
    • Mental Health Conditions Assessed?
    • Early Intervention
    • Multi-disorder Assessment
    • Testimonials
  • Conditions Assessed
    • Conditions Assessed
    • ADHD
      • More Detail
      • Symptoms
      • Assessment
      • Medication
      • Psychotherapy
      • Research
      • References
    • ADHD in Adults
      • More Detail
      • Treatment
      • References
    • Alcohol Dependence and Abuse
      • More Detail
      • Symptoms
      • Assessment
      • Treatment
      • References
    • Anorexia Nervosa
      • More Detail
      • Symptoms
      • Treatment
      • Research
      • References
    • Binge Eating Disorder
      • More Detail
      • Symptoms
      • Treatment
      • Research
      • References
    • Bipolar Disorder
      • More Detail
      • Symptoms
      • Medication
      • Psychotherapy
      • Other Treatment
      • Research
      • References
    • Bulimia Nervosa
      • More Detail
      • Symptoms
      • Treatment
      • Research
      • References
    • Depression
      • Symptoms
      • More Detail
      • Assessment
      • Medication
      • Psychotherapy
      • Other Treatment
      • References
    • Generalised Anxiety Disorder
      • More Detail
      • Medication
      • Psychotherapy
      • Research
      • References
    • Obsessive-Compulsive Disorder
      • More Detail
      • Symptoms
      • Assessment & Treatment
      • Medication
      • Psychotherapy
      • Research
    • Panic Disorder
      • More Detail
      • Symptoms
      • Assessment
      • Medication
      • Psychotherapy
      • Research
      • References
    • Post Traumatic Stress Disorder
      • More Detail
      • Symptoms
      • Medication
      • Psychotherapy
      • Research
      • References
    • Psychosis & Schizophrenia
      • More Detail
      • Symptoms
      • Assessment
      • Medication
      • Psychotherapy
      • References
    • Suicide & Suicidal Ideation
      • More Detail
      • Symptoms
      • Assessment
      • Treatment
      • References
  • About Us
    • Global Mind Screen Group
    • Partners
    • Mind Screen Centres
    • Mind Screen News
    • Workplace FAQs
    • Workplace Contact Us
    • Share with your Peers

Bipolar Disorder

Those with bipolar 2 disorders are more likely to also be diagnosed with substance use disorder, anxiety disorders and personality and eating disorders.

Bipolar Disorder
  • Conditions Assessed
  • ADHD
  • ADHD in Adults
  • Alcohol Dependence and Abuse
  • Anorexia Nervosa
  • Binge Eating Disorder
  • Bipolar Disorder
    • More Detail
    • Symptoms
    • Medication
    • Psychotherapy
    • Other Treatment
    • Research
    • References
  • Bulimia Nervosa
  • Depression
  • Generalised Anxiety Disorder
  • Obsessive-Compulsive Disorder
  • Panic Disorder
  • Post Traumatic Stress Disorder
  • Psychosis & Schizophrenia
  • Suicide & Suicidal Ideation
 
  • More Detail
  • Symptoms
  • Medication
  • Psychotherapy
  • Other Treatment
  • Research
  • References

Bipolar Disorder - References 

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602.

2. Akiskal HS. "Mood Disorders: Clinical Features. " in Sadock BJ, Sadock VA (ed). (2005). Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Lippincott Williams & Wilkins:Philadelphia.

3. Schneck CD, Miklowitz DJ, Miyahara S, Araga M, Wisniewski S, Gyulai L, Allen MH, Thase ME, Sachs GS. The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2008 Mar;165(3):370-7; quiz 410.

4. Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, Miyahara S, Shelton MD, Ketter TA, Goldberg JF, Bowden CL, Sachs GS. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry. 2004 Oct;161(10):1902-1908.

5. Goodwin FK, Jamison KR. (2007) Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, Second Edition. Oxford University Press:New York.

6. Constituency Survey: Living With Bipolar Disorder: How Far Have We Really Come? National Depressive and Manic-Depressive Association. 2001.

7. Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, Spagnolli S, Doria MR, Raimondi F, Endicott J, Dell'Osso L, Cassano GB. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity. Bipolar Disord. 2007 May;9(3):213-220.

8. Mueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher C, Vidaver R, Auciello P, Foy DW. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 1998 Jun;66(3):493-499.

9. Strakowski SM, Sax KW, McElroy SL, Keck PE, Jr., Hawkins JM, West SA. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Consult Clin Psychol. 1998 Sep;59(9):465-471.

10. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005 Jan-Feb;67(1):1-8.

11. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005 May 25;293(20):2528-2530.

12. Nurnberger JI, Jr., Foroud T. Genetics of bipolar affective disorder. Curr Psychiatry Rep. 2000 Apr;2(2):147-157.

13. Potash JB, Toolan J, Steele J, Miller EB, Pearl J, Zandi PP, Schulze TG, Kassem L, Simpson SG, Lopez V, MacKinnon DF, McMahon FJ. The bipolar disorder phenome database: a resource for genetic studies. Am J Psychiatry. 2007 Aug;164(8):1229-1237.

14. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res. 1997 Jul-Aug;31(4):393-432.

15. Soares JC, Mann JJ. The anatomy of mood disorders--review of structural neuroimaging studies. Biol Psychiatry. 1997 Jan 1;41(1):86-106.

16. Gogtay N, Ordonez A, Herman DH, Hayashi KM, Greenstein D, Vaituzis C, Lenane M, Clasen L, Sharp W, Giedd JN, Jung D, Nugent Iii TF, Toga AW, Leibenluft E, Thompson PM, Rapoport JL.
Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psychiatry. 2007 Sep;48(9):852-862.

17. Hirschfeld RM. Psychiatric Management, from "Guideline Watch: Practice Guideline for the Treatment of Patients With Bipolar Disorder, 2nd Edition". http://www.psychiatryonline.com/content.aspx?aID=148440. Accessed on February 11, 2008.

18. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med. 2000 Apr;Spec No.:1-104.

19. Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry. 2000 Sep 15;48(6):573-581.

20. Huxley NA, Parikh SV, Baldessarini RJ. Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry. 2000 Sep;8(3):126-140.

21. Miklowitz DJ. A review of evidence-based psychosocial interventions for bipolar disorder. J Consult Clin Psychol. 2006 67(Suppl 11):28-33.

22. Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, Frye MA, Keck PE, Jr., Leverich GS, Rush AJ, Suppes T, Pollio C, Drexhage HA. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002 Feb 15;51(4):305-311.

23. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Jr., Chou JC, Keck PE, Jr., Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ, Group DMS. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000 May;57(5):481-489.

24. Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005 Nov;162(11):2152-2161.

25. Vainionpaa LK, Rattya J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, Tekay A, Myllyla VV, Isojarvi JI. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol. 1999 Apr;45(4):444-450.

26. Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006 Jun 1;59(11):1078-1086.

27. Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biol Psychiatry. 2006 Dec 15;60(12):1378-1381.

28. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry. 1999 May;156(5):702-709.

29. Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry. 2000 Sep 15;48(6):558-572.

30. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007 Apr 26;356(17):1711-1722.

31. MedlinePlus Drug Information:
Lithium. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a681039.html. Accessed on Nov 19, 2007.

32. MedlinePlus Drug Information:
Carbamazepine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682237.html. Accessed on July 13, 2007.

33. MedlinePlus Drug Information: Lamotrigine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a695007.html. Accessed on February 12, 2008.

34. MedlinePlus Drug Information: Valproic Acid. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682412.html. Accessed on February 12, 2008.

35. MedlinePlus Drug Information: Topiramate. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a697012.html. Accessed on Febrary 22, 2008.

36. MedlinePlus Drug Information: Gabapentin. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a694007.html. Accessed on February 22, 2008.

37. MedlinePlus Drug Information: Oxcarbazepine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601245.html. Accessed on February 22, 2008.

38. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 Sep 22;353(12):1209-1223.

39. Llewellyn A, Stowe ZN, Strader JR, Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Consult Clin Psychol. 1998 59(Suppl 6):57-64.

40. Viguera AC, Whitfield T, Baldessarini RJ, Newport J, Stowe Z, Reminick A, Zurick A, Cohen LS. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer diskontinuation. Am J Psychiatry. 2007 Dec;164(12):1817-1824.

41. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004 Apr;161(4):608-620.

42. Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program (STEP). Arch Gen Psychiatry. 2007 Apr;64(4):419-426.

43. Pandya M, Pozuelo L, Malone D.
Electroconvulsive therapy: what the internist needs to know. Cleve Clin J Med. 2007 Sep;74(9):679-685.

44. Mental Health: A Report of the Surgeon General. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health. 1999.

45. Nierenberg AA, Burt T, Matthews J, Weiss AP.
Mania associated with St. John's wort. Biol Psychiatry. 1999 Dec 15;46(12):1707-1708.

46. Henney JE. From the Food and Drug Administration: Risk of Drug Interactions With St John's Wort. JAMA. 2000 Apr 5;283(13):1679.

47. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB.
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 May;56(5):407-412.

48. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Jr., Marangell LB, Richardson AJ, Lake J, Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Consult Clin Psychol. 2006 Dec;67(12):1954-1967.

49. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006 Feb;163(2):217-224.

50. Perlick DA, Rosenheck RA, Clarkin JF, Maciejewski PK, Sirey J, Struening E, Link BG. Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatr Serv. 2004 Sep;55(9):1029-1035.

Share this page

Enquire Now
Facebook LinkedIn Logo Twitter Google+
Share with a Peer

Mind Screen TV

The most important lesson...
The most important lesson from 83,000 brain scans: Daniel Amen
Depression is a Disease of...
Depression is a Disease of Civilization: Stephen Ilardi at TEDxEmory
Mental Health Transitions
Mental Health Transitions
Ian Thorpe Shares Struggles...
Ian Thorpe Shares Struggles with Depression, Sexuality and Olympics
100,000 Australian's...
100,000 Australian's Missing Out on Mental Health Services
Vikram Patel: Mental Health...
Vikram Patel: Mental Health for All by Involving All
Stephen Fry Talks About His...
Stephen Fry Talks About His Depression

Mind Screen News

Mind Screen Places 4th in...
Mind Screen places 4th in the Readers' Choice segment of the 2014 Anthill Magazine SMART 100 Top Innovations in Australia. In fact, of the three innovations that placed higher than Mind Screen, ..
Western Australia Mental...
Mind Screen has been nominated for the Government of Western Australia Mental Health Commission Good Outcome Awards 2012. It as been nominated in Category Three: The Edith Cowan Univer..
Mind Screen 27-Country...
Global Mind Screen Group Pty Ltd signed a Territory Licence Agreement with Latin America Business Services Inc (LABS Global) on the 9th of June 2012. The Territory Licence covers 27 countrie..
Hospital das Clínicas,...
Following 5 months of user acceptance testing, software customisation for the Brazilian market and translation fine tuning, LABS Global (Mind Screen Group's Latin American commercialisation par..
University of Sao Paulo Study
GMS through its Brazilian licensee LABS Brazil has commenced a University of Sao Paulo IPq inter-departmental study on the Mind Screen. The results of this and two other Brazilian studies are expect..

Mental Health News

Family Physicians Screening...
Family Physicians are not always the best judges of depression, according to an Australian study which showed the aid of a simple computer tablet to be a better bet for diagnosis. When identifyin..
Victoria's behavioral...
A new report says strain on Victoria's behavioral health system   has resulted in a sharp rise in people using hospital emergency departments to access treatment. The Victorian Hea..
Amphetamine abuse the...
For the first time, amphetamine   abuse is the number one problem for people seeking treatment for drug addiction, according to Australia's largest rehabilitation service. Sydney's..
Talking About Mental Health...
Asian countries such as Korea, China, Japan and India have troubling suicide rates. Despite this, diskussing behavioral health issues   like depression or anxiety often does not happen in..
One in Eight Deaths of...
One in eight deaths of Australians aged under 25 is now related to alcohol consumption, a report has revealed. The   Australian National Council on Drugs report  (ANCD..

How It Works

  • What is a Mind Screen?
  • How it Works
  • Process Flow Chart
  • Practitioner Benefits
  • Why Refer Your Patients?

Testimonials

  • Practitioner Testimonials
  • Patient/Client Testimonials
  • Case Studies

Workplace FAQs

  • Product
  • Registration
  • Financial
  • Internet
  • Practical
FacebookLinkedIn LogoTwitter AWS logo footerDigiCert Logo

About

  • GMS Group Since 2003
  • Contact Us
  • Company FAQs
  • Partners
  • Mind Screen Centres

Media

  • Mind Screen News!
  • Mental Health News
  • MyMindScreen - Facebook

Info For....

  • Investors
  • Philanthropists
  • NGOs/Charities
  • Academics/Researchers

Legal

  • Terms of Use
  • Security & Privacy
  • Site Map
 
Copyright © 2003-2014 Global Mind Screen Group Pty Ltd